HealthLynked Sells ACO Health Partners Subsidiary

HealthLynked Sells ACO Health Partners Subsidiary

HealthLynked announced on January 20 that it has signed a definitive agreement to sell its ACO Health Partners subsidiary to PBACO Holding, LLC, which operates under the name Palm Beach Accountable Care Organization (PBACO). According to data captured in the LevinPro HC database, this acquisition represents the first accountable care organization (ACO)  transaction of 2023. There was just one ACO deal announced during 2022. Under the terms of the agreement, HealthLynked will receive $750,000 in cash, as well as up to $2.25 million incremental cash based on agreement to participate in PBACO by AHP’s existing physician practices or newly added practices, scaled based on the number... Read More »
​​Montecito Medical Acquires 6-Building MOB Portfolio in Kansas City Area

​​Montecito Medical Acquires 6-Building MOB Portfolio in Kansas City Area

Montecito Medical Real Estate, a leading acquirer of medical office properties nationwide, has completed its acquisition of a six-building medical office building (MOB) portfolio in the greater Kansas City marketplace. The seller and anchor tenant in the transaction were represented by Collin Hart and Marc Flynn of ERE Healthcare Real Estate Advisors. The portfolio acquisition expands Montecito’s footprint in the Kansas City area. Terms of the deal were not disclosed. The buildings, which total 95,769 square feet, are tenanted by Discover Vision Centers. The six properties are located in Kansas City, Olathe and Leawood, Kansas, as well as Raymore, Independence and Blue Springs, Missouri.... Read More »
Tigermed Acquires Marti Farm

Tigermed Acquires Marti Farm

Hangzhou, China-based Tigermed has acquired Zagreb, Croatia-based Marti Farm. Terms of the deal were not disclosed. Marti Farm is a contract research organization (CRO) dedicated to assisting the healthcare, pharmaceutical and food supplement sectors in developing and delivering health-improving outcomes. The company’s global reach is expanding, with results delivered in more than 50 countries to more than 150 clients. Tigermed is a global provider of integrated research and development solutions for the biopharmaceutical and medical device industries. Tigermed represents a worldwide network of more than 100 subsidiaries and 180 service locations with more than 10,000 employees... Read More »
PAM Group Acquires MedProtect in UK Deal

PAM Group Acquires MedProtect in UK Deal

PAM Group has acquired MedProtect in a deal involving companies based in the United Kingdom. James Redshaw of law firm Hill Dickinson’s corporate team in Manchester advised PAM Group. Terms of the deal were not disclosed. MedProtect provides occupational health screening to companies across a range of industries, with a strong presence in the automotive sector, and where employees are exposed to hazardous substances such as fumes, dust or chemicals, or are operating in noisy environments. PAM Group is an occupational health and well-being specialist. The company employs more than 700 people. According to data captured in the LevinPro HC database, this represents the third occupational... Read More »
Essence Investment Acquires AMP Alternative Medical Products

Essence Investment Acquires AMP Alternative Medical Products

Essence Investment AG has acquired AMP Alternative Medical Products GmbH. Essence anticipates that its Swiss-based portfolio companies, Marry Jane AG and Swiss Extract AG, will benefit from AMP’s distribution capacity in Germany’s large and growing medical cannabis market. Terms of the deal were not disclosed. AMP Alternative Medical Products is licensed to import European Union – Good Manufacturing Practice medical cannabis and sell to pharmaceutical distributors or pharmacists. Importing medical cannabis from the Netherlands, Canada and Denmark, AMP is supplying approximately 150 pharmacies throughout Germany. Essence Investment is a Swiss company providing cannabis products... Read More »
TA Associates Announces Strategic Growth Investment in Synokem Pharmaceuticals

TA Associates Announces Strategic Growth Investment in Synokem Pharmaceuticals

TA Associates, a leading global growth private equity firm, announced on January 18 that it completed a strategic growth investment in Synokem Pharmaceuticals Ltd. TA Associates was represented by AZB & Partners. BDA Partners acted as the financial adviser to Synokem. Synokem’s founders will continue as shareholders in Synokem alongside TA. Financial terms of the transaction were not disclosed. Founded in 1983, Synokem Pharmaceuticals is one of India’s leading contract development and manufacturing organizations (CDMOs), serving customers in the branded generic domestic formulations market. Synokem is based in New Delhi, India, with manufacturing and R&D facilities in Haridwar,... Read More »